This webinar will guide you through the expectations of regulators when filing a Pharmaceutical Continuous Manufacturing (PCM) process for an Oral Solid Dose (OSD) drug product. Starting from the difference between a batch and a continuous process we cover the impact of evidence that needs to be generated so that the quality of the released product is assured, and how this will evolve throughout the drug product lifecycle. FDA, EMA, ICH [Q13].
Complete the form below to access the on-demand webinar:
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
22320 Foothill Blvd. Suite 330, Hayward CA 94541
